AU2018272839B2 - Fractionated antimicrobial compositions and use thereof - Google Patents

Fractionated antimicrobial compositions and use thereof Download PDF

Info

Publication number
AU2018272839B2
AU2018272839B2 AU2018272839A AU2018272839A AU2018272839B2 AU 2018272839 B2 AU2018272839 B2 AU 2018272839B2 AU 2018272839 A AU2018272839 A AU 2018272839A AU 2018272839 A AU2018272839 A AU 2018272839A AU 2018272839 B2 AU2018272839 B2 AU 2018272839B2
Authority
AU
Australia
Prior art keywords
cancer
nci
infection
molecular weight
polymer fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018272839A
Other languages
English (en)
Other versions
AU2018272839A2 (en
AU2018272839A1 (en
AU2018272839A8 (en
Inventor
Konstantin Andreevich Krasnov
Georgy Viktorovich Tets
Viktor Veniaminovich Tets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2018272839A1 publication Critical patent/AU2018272839A1/en
Publication of AU2018272839A8 publication Critical patent/AU2018272839A8/en
Publication of AU2018272839A2 publication Critical patent/AU2018272839A2/en
Application granted granted Critical
Publication of AU2018272839B2 publication Critical patent/AU2018272839B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/08—Polyhydrazides; Polytriazoles; Polyaminotriazoles; Polyoxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2018272839A 2017-05-24 2018-05-22 Fractionated antimicrobial compositions and use thereof Active AU2018272839B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762510446P 2017-05-24 2017-05-24
US62/510,446 2017-05-24
US201862633761P 2018-02-22 2018-02-22
US62/633,761 2018-02-22
PCT/US2018/033880 WO2018217743A1 (en) 2017-05-24 2018-05-22 Fractionated antimicrobial compositions and use thereof

Publications (4)

Publication Number Publication Date
AU2018272839A1 AU2018272839A1 (en) 2019-12-19
AU2018272839A8 AU2018272839A8 (en) 2020-01-16
AU2018272839A2 AU2018272839A2 (en) 2020-06-25
AU2018272839B2 true AU2018272839B2 (en) 2024-12-05

Family

ID=64395893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018272839A Active AU2018272839B2 (en) 2017-05-24 2018-05-22 Fractionated antimicrobial compositions and use thereof

Country Status (9)

Country Link
US (1) US11285170B2 (enExample)
EP (1) EP3630082A4 (enExample)
JP (1) JP7475144B2 (enExample)
CN (1) CN111093646A (enExample)
AU (1) AU2018272839B2 (enExample)
BR (1) BR112019024628A2 (enExample)
CA (1) CA3064733A1 (enExample)
IL (1) IL270759B2 (enExample)
WO (1) WO2018217743A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117425473A (zh) * 2021-04-05 2024-01-19 维克托·泰茨 生物活性产品

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2039735C1 (ru) 1993-04-29 1995-07-20 Петр Александрович Гембицкий Способ получения дезинфицирующего средства
WO1996028570A1 (en) 1995-03-09 1996-09-19 Xechem, Inc. A rapid method of and diagnostic kit for the detection of microorganisms
US6984499B2 (en) 1997-10-02 2006-01-10 Idexx Laboratories, Inc. Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility
RU2141452C1 (ru) 1998-05-26 1999-11-20 ООО "Торговый дом "Красный химик" Способ получения кобальт (ii) сульфата
RU2176651C2 (ru) 1999-11-11 2001-12-10 Институт эколого-технологических проблем Способ получения блоксополимера алкиленгуанидина с полиалкиленамином и блоксополимер
WO2001082937A1 (en) 2000-04-28 2001-11-08 Fziomed, Inc. Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
RU2176523C1 (ru) 2000-06-16 2001-12-10 Региональная общественная организация - Институт эколого-технологических проблем Дезинфицирующее средство при туберкулезе
BR0309758A (pt) 2002-05-03 2005-02-15 Schering Ag Tiazolidinonas e seu uso como inibidortes de cinase semelhante a polo
US8100872B2 (en) 2002-10-23 2012-01-24 Tyco Healthcare Group Lp Medical dressing containing antimicrobial agent
WO2004046109A2 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Ionene oligomers and polymers
RU2230734C1 (ru) 2003-06-09 2004-06-20 Общество с ограниченной ответственностью "Международный институт эколого-технологических проблем" Производные полигуанидинов
JP4629987B2 (ja) * 2004-03-19 2011-02-09 日本ペイント株式会社 シーリング剤、リン酸塩処理鋼板の被覆方法及びリン酸塩処理鋼板
CA2565556A1 (en) * 2004-05-03 2005-12-08 Neosil, Inc. Polycationic antimicrobial therapeutic
RU2324478C2 (ru) 2006-06-27 2008-05-20 Общество с ограниченной ответственностью "Международный институт эколого-технологических проблем" Способ получения биоцидного полигуанидина и биоцидный полигуанидин
WO2008008912A1 (en) 2006-07-14 2008-01-17 Genelabs Technologies, Inc. Antiviral agents
RU2422137C1 (ru) 2009-10-08 2011-06-27 Виктор Вениаминович Тец Способ получения биоцидного полигуанидина и биоцидный полигуанидин
RU2423359C1 (ru) 2009-12-02 2011-07-10 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Противовирусное средство
WO2011135577A1 (en) 2010-04-29 2011-11-03 Bios Agricorp Pvt. Ltd. Polyhexamethyleneguanidine and its salts based disinfectant.
CN102453315B (zh) * 2010-10-22 2014-05-28 中国石油化工股份有限公司 一种抗菌防霉聚乳酸组合物及其制备方法
EP3513803B1 (en) 2011-04-27 2021-05-19 Biom'up France Sas Hemostatic compositions
RU2480227C2 (ru) 2011-07-01 2013-04-27 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВИ "Вектор") Противовирусное средство на основе меланина
KR102143252B1 (ko) 2011-10-11 2020-08-11 백스터 인터내셔널 인코포레이티드 지혈 조성물
US8829053B2 (en) 2011-12-07 2014-09-09 Rochal Industries Llp Biocidal compositions and methods of using the same
RU2533232C2 (ru) 2012-07-20 2014-11-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вирусологии им. Д.И. Ивановского" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ вирусологии им. Д.И. Ивановского" Минздравсоцразвития России Применение поликарбоксильного производного фуллерена в качестве микробицидного противовирусного средства
US9439433B2 (en) * 2013-05-22 2016-09-13 Curza Global, Llc Compositions and methods comprising a biocidal polyamine
CN103705535A (zh) 2013-12-27 2014-04-09 王东宇 壳聚糖妇科凝胶及其制备方法
RU2546006C1 (ru) * 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
EP3248596B1 (en) * 2015-01-20 2023-12-06 Tets, Viktor Veniaminovich Hemostatic agent

Also Published As

Publication number Publication date
CA3064733A1 (en) 2018-11-29
AU2018272839A2 (en) 2020-06-25
CN111093646A (zh) 2020-05-01
RU2019139930A3 (enExample) 2021-09-16
EP3630082A1 (en) 2020-04-08
EP3630082A4 (en) 2021-12-15
RU2019139930A (ru) 2021-06-24
IL270759B2 (en) 2025-01-01
IL270759A (en) 2020-01-30
AU2018272839A1 (en) 2019-12-19
JP2020521838A (ja) 2020-07-27
AU2018272839A8 (en) 2020-01-16
BR112019024628A2 (pt) 2020-06-16
IL270759B1 (en) 2024-09-01
JP7475144B2 (ja) 2024-04-26
US20200113932A1 (en) 2020-04-16
WO2018217743A1 (en) 2018-11-29
US11285170B2 (en) 2022-03-29

Similar Documents

Publication Publication Date Title
US8455490B2 (en) Facially amphiphilic polymers and oligomers and uses thereof
CA2259033C (en) New guanidine derivatives, methods of preparing them and their use as drugs
AU2018272839B2 (en) Fractionated antimicrobial compositions and use thereof
JPS61227529A (ja) アクタガルジンの塩基性モノアミド誘導体及びその付加塩
EP3578566B1 (en) Biocidal peptide and preparation based thereon
JP2013521330A (ja) 抗菌剤として有用なペプチド化合物
AU2005208771B2 (en) Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
US20120115877A1 (en) Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating Cancer
RU2795891C2 (ru) Фракционированные антимикробные композиции и их применение
JP6486270B2 (ja) 環状骨格ペプチドの組合せ
Bürli et al. DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids
WO2019085926A1 (zh) 多黏菌素类似物及其制备方法
Babbar et al. General Aspects, Applications, and Recent Advancements of 1, 2-Disubstituted Benzimidazole Mannich Bases: A Privileged Scaffold
EP4249500A2 (en) Peptide entities with antimicrobial activity against multi-drug resistant pathogens
CN119431249B (zh) 菲并[9,10−d]咪唑季铵盐类衍生物及其制备方法和抗菌应用
CN120248046B (zh) 一种具有广谱抗菌活性的抗菌肽ma25及其应用
US20230086360A1 (en) Antimicrobial Peptides
EP1572226B1 (de) Peptide mit hohem cysteingehalt
US20220193241A1 (en) Agent targeting double-membrane organelle dna
JP2025542404A (ja) トリプトファンに富み、自己組織化特性を有する抗菌ペプチドおよびその応用
DAULATRAO et al. Biological Significance of Benzimidazole Derivatives: A Review.
CN120248034A (zh) 一种具有广谱抗菌活性的抗菌肽gk18及其应用
CN120248033A (zh) 一种具有广谱抗菌活性的抗菌肽mm19及其应用
CN117897394A (zh) 具有抗微生物活性的胜肽
BR102015028254A2 (pt) peptídeo sintético e seu uso como antimicrobiano

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 33 , NO 49 , PAGE(S) 6985 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME TETS, VIKTOR VENIAMINOVICH; TETS, VIKTOROVICH GEORGY, APPLICATION NO. 2018272839, UNDER INID (71) CORRECT THE APPLICANT NAME TO TETS, VIKTOR VENIAMINOVICH; TETS, GEORGY VIKTOROVICH

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT FILED 03 JUN 2020

FGA Letters patent sealed or granted (standard patent)